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Background
LGE is widely used as a means to quantify scar or fibrotic
tissue in patients suffering from cardiomyopathies. In clin-
ical routine 2D data acquisition is most commonly prac-
ticed, albeit having the drawback of multiple breath-holds
and long acquisition times. 3D acquisition can significantly
reduce acquisition time. This leads to shortened scan time
and a more efficient use of available MRI resources. So
our purpose was to determine whether the quantification
of myocardial fibrosis in patients with Fabry disease and
hypertrophic cardiomyopathy (HCM) using a late gadoli-
nium enhancement (LGE) single-breath-hold three-
dimensional (3D) inversion recovery magnetic resonance
(MR) imaging sequence is comparable with a clinically
established two-dimensional (2D) multi-breath-hold
sequence.
Methods
40 consecutive patients (18 men; mean age 50 ± 17)
with either Fabry disease (n = 18) or HCM (n = 22)
were enrolled in this prospective study. Studies were
conducted on a 1.5-T clinical MR imaging system.
Spatial resolution was the same for 3D and 2D images
(field-of-view, 350 × 350 mm2; in-plane-resolution,
1.2 × 1.2 mm2; section-thickness, 8 mm). Datasets were
analyzed for subjective image and quantitative evalua-
tion of myocardial mass (grams), fibrotic mass (grams)
and total fibrotic tissues percentage. Statistical analysis
included Wilcoxon-signed-rank test, student’s t-test for
paired samples and Bland-Altman analysis.
Results
There was no significant difference in subjective image
quality between acquisitions (P > 0.1) for either disease.
In patients with Fabry disease there was no significant
differences in myocardial mass between 3D (100.7 g ±
30.8 g) and 2D acquisition(99.9 g ± 31.9 g; P = 0.55), as
well as for fibrous tissue mass(3.9 g ± 6.4 g vs 4.0 ± 6.4 g;
P = 0.89) and total fibrous percentage (3.4% ± 5.5% vs
3.4 ± 5.5; P = 0.89). Bland-Altman analysis showed good
agreement between 3D and 2D datasets for myocardial
mass(mean difference: 0.8 g; limits of agreement: -10.2 g
- 11.8 g), fibrous tissue mass (mean difference: -0.02 g;
limits of agreement: -1.45 g-1.41 g), total fibrous percen-
tage (mean difference:0.02%; limits of agreement: -1.31%-
1.35%). In patients with HCM there was no significant
differences in myocardial mass between 3D (115.5 g ±
33.3 g) and 2D acquisition (116.7 g ± 33.6 g; P = 0.48), as
well as for fibrous tissue mass (5.6 g ± 8.6 g vs 5.7 g ± 8.7 g;
P = 0.6) and total fibrous percentage (4.3% ± 6.4% vs
4.3% ± 6.5%; P = 0.89). Bland-Altman analysis showed good
agreement between 3D and 2D datasets for myocardial
mass (mean difference: -1.2 g; limits of agreement:-16.1 g -
13.7 g), fibrous tissue mass (mean difference -0.08 g; limits
of agreement: -1.33 g - 1.17 g), total fibrous percentage
(mean difference:-0.01 g; limits of agreement:-1.01 g-0.99 g).
Acquisition time was significantly shorter for 3D sequences
(24.9 seconds ± 5.2 seconds) as compared to 2D sequence
(349.1 seconds ± 62.3 seconds, P < 0.001).
Conclusions
3D LGE imaging enables comparable quantification of
fibrous myocardial tissue compared to a 2D sequence at
a faster acquisition rate.
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